Fibrocell Science Inc (NASDAQ:FCSC)

0.622
Delayed Data
As of Apr 20
 -0.016 / -2.51%
Today’s Change
0.51
Today|||52-Week Range
4.64
-2.81%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$13.1M

Company Description

Fibrocell Science, Inc. is an autologous cell and gene therapy company, which engages in translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. The company was founded on September 1, 2009 and is headquartered in Exton, PA.

Contact Information

Fibrocell Science, Inc.
405 Eagleview Boulevard
Exton Pennsylvania 19341
P:(484) 713-6000
Investor Relations:
(484) 713-6133

Employees

Shareholders

Individual stakeholders29.19%
Other institutional13.50%
Mutual fund holders1.54%

Top Executives

John M. MaslowskiPresident, CEO, CFO & Director
Sean D. BuckleySecretary & Vice President-Business Administration
Lisa A. EmbonVice President-Corporate Accounting & Controller
Karen CaseyInvestor & Media Relations Contact
Pamela A. SwiggardVP-Regulatory Affairs & Quality Assurance